Abstract
Background
Cervical esophageal cancer (CEC) carries a poor prognosis; however, due to its low incidence, optimal treatment for CEC remains to be established. The purpose of this study was to clarify the current status of treatment of CEC in Japan and obtain evidence for establishing the appropriate treatment method.
Patients and methods
We asked specialist training facilities accredited by the Japanese Broncho-Esophageal Society to register data on CEC cases that received curative treatment from January 2009 to December 2014, and conducted a retrospective review of the clinical data of 302 cases registered from 27 facilities.
Results
In regard to the initial therapy, of the 302 patients, 33 had undergone endoscopic resection, 41 had undergone surgery, 67 had received induction chemotherapy (IC), and 143 had received chemoradiotherapy (CRT). There were no significant differences in the 5-year overall survival rates among the patient groups that had received surgery, IC or CRT as the initial treatment; advanced stage and recurrent nerve invasion were identified as independent poor prognostic factors. Among the patients who had received IC or CRT as laryngeal-preserving surgery was not indicated at the time of the initial diagnosis, the functional laryngeal preservation rate at the end of the observation period was 34.8%.
Conclusion
Even in patients with advanced CEC, there is the possibility of preserving the larynx by adopting IC or CRT. However, if the laryngeal function cannot be preserved, there is a risk of complications from aspiration pneumonia, so that the choice of treatment should be made carefully.
Similar content being viewed by others
References
Buckstein M, Liu J. Cervical esophageal cancers: challenges and opportunities. Curr Oncol Rep. 2019;21:46. https://doi.org/10.1007/s11912-019-0801-7.
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.
van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van B Henegouwen MI, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, et al. Comprehensive registry of esophageal cancer in Japan, 2012. Esophagus. 2019;16:221–45. https://doi.org/10.1007/s10388-019-00674-z.
NCCN Guidelines Panel. Esophageal and esophagogastric junction cancers v. 2.2018. Nccn [Internet]. 2017. Available from: https://www.dropbox.com/s/zz62u2s3oy0p2zm/esophagealNCCN.pdf?dl=0.
Valmasoni M, Pierobon ES, Zanchettin G, Briscolini D, Moletta L, Ruol A, et al. Cervical esophageal cancer treatment strategies: a cohort study appraising the debated role of surgery. Ann Surg Oncol. 2018;25:2747–55.
Tateya I, Muto M, Morita S, Miyamoto S, Hayashi T, Funakoshi M, et al. Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc. 2016;30:323–9.
Iizuka T, Kikuchi D, Hoteya S, Kajiyama Y, Kaise M. Efficacy and safety of endoscopic submucosal dissection for superficial cancer of the cervical esophagus. Endosc Int Open. 2017;05:E736–41.
Watanabe A, Taniguchi M, Kimura Y, Hosokawa M, Ito S, Tsukamoto S, et al. Synopsis of transoral endoscopic laryngopharyngeal surgery for superficial pharyngeal cancers. Head Neck. 2017;39:1779–87.
Ong GB, Lee TC. Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus. Br J Surg. 1960;48:193–200. https://doi.org/10.1002/bjs.18004820823.
Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pöttgen C. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus. 2014;27:678–84.
Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys. 2008;71:735–40.
Burmeister BH, Dickie G, Smithers BM, Hodge R, Morton K. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg. 2000;126:205–8.
Vainshtein JM, Wu VF, Spector ME, Bradford CR, Wolf GT, Worden FP. Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer. Expert Rev Anticancer Ther. 2013;13:1053–64.
Nakata Y, Hanai N, Nishikawa D, Suzuki H, Koide Y, Fukuda Y, et al. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma. Int J Clin Oncol. 2017;22:1034–41.
Takebayashi K. Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer. Dis Esophagus. 2017;30:1–5.
Zhang P, Xi M, Zhao L, Qiu B, Liu H, Hu YH, et al. Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol. 2015;116:257–61.
Cao CN, Luo JW, Gao L, Xu GZ, Yi JL, Huang XD, et al. Primary radiotherapy compared with primary surgery in cervical esophageal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140:918–26.
Du XX, Yu R, Wang ZF, Du DC, Liu QY, Wang RM, et al. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy. Bosn J Basic Med Sci. 2019;19:186–94.
Dai K-Y, Yu Y-C, Leu Y-S, Chi C-W, Chan M-L, Tsai C-H, et al. Neoadjuvant chemoradiotherapy and larynx-preserving surgery for cervical esophageal cancer. J Clin Med. 2020;9:387.
Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96:166–72.
Sun F, Li X, Lei D, Jin T, Liu D, Zhao H, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014;7:2771–8.
Kato H, Kitagawa Y, Kuwano H, Toh Y, Kusano M, Oyama T, et al. Neo-adjuvant therapy or definitive chemoradiotherapy can improve laryngeal preservation rates in patients. A Japanese nationwide survey. Esophagus. 2016;13:276–82.
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst. 1996;88:890–9.
Wolf GT, Hong WK, Fisher SG, Urba SG. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
Forastier AA, Goepfert H, Maor M, Pajak TF. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
Lefebvre J-L, Ang KK, on behalf of the Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Head Neck. 2009;31:429–41.
Chou SH, Li HP, Lee JY, Huang MF, Lee CH, Lee KW. Radical resection or chemoradiotherapy for cervical esophageal cancer? World J Surg. 2010;34:1832–9.
Miyamoto S, Sakuraba M, Nagamatsu S, Hayashi R. Salvage total pharyngolaryngectomy and free jejunum transfer. Laryngoscope. 2011;121:947–51.
Ganly I, Patel S, Matsuo J, Singh B, Kraus D, Boyle J, et al. Postoperative complications of salvage total laryngectomy. Cancer. 2005;103:2073–81.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
This study was conducted in accordance with the principles of the Declaration of Helsinki (1964) and its later versions, and information about the study was disclosed by displaying posters at each participating institution. At our institution, information about the study was disclosed on the website of the Bioethics Research Center.
Conflict of interest
The authors declare that they have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ohno, K., Nasu, M., Matsui, H. et al. Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer. Esophagus 19, 576–585 (2022). https://doi.org/10.1007/s10388-022-00921-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-022-00921-w